Literature DB >> 1745341

Hearing loss in facioscapulohumeral muscular dystrophy.

O F Brouwer1, G W Padberg, C J Ruys, R Brand, J A de Laat, J J Grote.   

Abstract

The coincidence of facioscapulohumeral muscular dystrophy (FSHD) with sensorineural hearing loss and retinal abnormalities might imply genetic heterogeneity of FSHD. We performed screening audiometry in 56 patients with autosomal dominant FSHD and in 72 healthy family members, and found that the difference in hearing level between 4,000 Hz and 6,000 Hz was significantly greater in FSHD patients than in controls, independently both for the left and right ear. We conclude that this change of hearing function is part of the disease and may lead to severe hearing loss in some patients. The fact that it was present in all families is another argument against genetic heterogeneity.

Entities:  

Mesh:

Year:  1991        PMID: 1745341     DOI: 10.1212/wnl.41.12.1878

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Petra G M Van Overveld; Lodewijk A Sandkuijl; Harry Vrieling; George W Padberg; Rune R Frants; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2004-05-20       Impact factor: 11.025

Review 2.  A role for epigenetics in hearing: Establishment and maintenance of auditory specific gene expression patterns.

Authors:  Matthew J Provenzano; Frederick E Domann
Journal:  Hear Res       Date:  2007-07-19       Impact factor: 3.208

Review 3.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

4.  Association of retinal vasculitis (Eales' disease) and Meniere-like vestibulocochlear symptoms.

Authors:  Wolfgang Wagner; Astrid Fehrmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-08-24       Impact factor: 2.503

5.  Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.

Authors:  Yara Bou Saada; Carla Dib; Petr Dmitriev; Aline Hamade; Gilles Carnac; Dalila Laoudj-Chenivesse; Marc Lipinski; Yegor S Vassetzky
Journal:  Histochem Cell Biol       Date:  2016-02-09       Impact factor: 4.304

6.  β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.

Authors:  Christopher R S Banerji; Paul Knopp; Louise A Moyle; Simone Severini; Richard W Orrell; Andrew E Teschendorff; Peter S Zammit
Journal:  J R Soc Interface       Date:  2015-01-06       Impact factor: 4.118

Review 7.  Emerging preclinical animal models for FSHD.

Authors:  Angela Lek; Fedik Rahimov; Peter L Jones; Louis M Kunkel
Journal:  Trends Mol Med       Date:  2015-03-20       Impact factor: 11.951

8.  De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1).

Authors:  P E Jardine; M C Koch; P W Lunt; J Maynard; K D Bathke; P S Harper; M Upadhyaya
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

9.  Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene.

Authors:  Abhijit Dandapat; Darko Bosnakovski; Lynn M Hartweck; Robert W Arpke; Kristen A Baltgalvis; Derek Vang; June Baik; Radbod Darabi; Rita C R Perlingeiro; F Kent Hamra; Kalpna Gupta; Dawn A Lowe; Michael Kyba
Journal:  Cell Rep       Date:  2014-08-28       Impact factor: 9.423

Review 10.  MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness.

Authors:  Lilach M Friedman; Karen B Avraham
Journal:  Mamm Genome       Date:  2009-10-30       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.